The End TB Strategy stipulates that major technological breakthroughs are needed by 2025, so that the rate at which TB incidence falls can be accelerated dramatically compared with historic levels. Delivering on these targets requires a multisectoral approach to developing and equitably diffusing the right medical innovations and strategies as a top priority. The main aim of investing in research and innovations on TB is to ensure providing simpler and quicker diagnostic services.
Invest in research and Innovative practices in the ever evolving and dynamic healthcare environment to identify effective and simpler solutions to achieve a TB Free India.
Despite TB being a curable disease and free of cost treatment being provided by the Government, India continues to have the highest incidence of TB in the world along with highest TB mortality. Prime Minister Mr Narendra Modi committed to eliminate TB in India by 2025. It is an ambitious target and there is a need for increased investments and partnerships by all sectors including the corporate sector to contribute to the goal of making India TB free. These partnerships will not only save lives but also help your brand gain the visibility it deserves as it cares for its people and communities, and support interventions with measurable outcomes.
Delay in accurate diagnosis of tuberculosis in India is also due to untrained first line of contact, be it allopaths or alternative medicine.